Open Access Review Article

Intralesional Bleomycin Sclerotherapy in Children with Lymphangiomas: A Review Article

Volkan Sarper Erikci*

Sağlik Bilimleri University, Department of Pediatric Surgery, Tepecik Training Hospital, Turkey

Corresponding Author

Received Date: November 25, 2020;  Published Date:December 14, 2020

Abstract

Lymphangioma is a benign tumor of lymphatic vessels. Swelling and cosmetic deformity are the most common symptoms. As a sclerosing agent, bleomycin has been used in the management of patients with these lesions with successful outcomes. In this review the topic is discussed, and a brief literature review is given. Intralesional injection of bleomycin in children with lymphangioma is an effective method of treatment and it usually achieves excellent results in most of the patients with minimal side effects.

Keywords: Lymphangioma; Bleomycin; Intralesional sclerotherapy

Citation
Signup for Newsletter
Scroll to Top